| 000 | 01785 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513083242.0 | ||
| 264 | 0 | _c19960124 | |
| 008 | 199601s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.92.25.11889 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKolesnitchenko, V | |
| 245 | 0 | 0 |
_aHuman immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cDec 1995 |
||
| 300 |
_a11889-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aCD4 Antigens _xmetabolism |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCDC2 Protein Kinase _xmetabolism |
| 650 | 0 | 4 | _aCell Communication |
| 650 | 0 | 4 |
_aCell Separation _xmethods |
| 650 | 0 | 4 |
_aCyclins _xmetabolism |
| 650 | 0 | 4 | _aCytopathogenic Effect, Viral |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 | _aG2 Phase |
| 650 | 0 | 4 | _aHIV Envelope Protein gp120 |
| 650 | 0 | 4 |
_aHIV Infections _xpathology |
| 650 | 0 | 4 |
_aHIV-1 _xisolation & purification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xpathology |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aWahl, L M | |
| 700 | 1 | _aTian, H | |
| 700 | 1 | _aSunila, I | |
| 700 | 1 | _aTani, Y | |
| 700 | 1 | _aHartmann, D P | |
| 700 | 1 | _aCossman, J | |
| 700 | 1 | _aRaffeld, M | |
| 700 | 1 | _aOrenstein, J | |
| 700 | 1 | _aSamelson, L E | |
| 700 | 1 | _aCohen, D I | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 92 _gno. 25 _gp. 11889-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.92.25.11889 _zAvailable from publisher's website |
| 999 |
_c8523976 _d8523976 |
||